Company Announcements

Contineum Therapeutics Sets Executive Severance Plan

Contineum Therapeutics, Inc. Class A (CTNM) has shared an announcement.

Contineum Therapeutics, Inc. has implemented an Executive Severance Plan to provide security for its top executives and select employees in case of involuntary separation from the company. Executives like CEO Carmine Stengone are eligible for a year’s salary and a portion of their bonus in severance, with added benefits and full vesting of equity awards if the termination is related to a change in control of the company. The plan includes various tiers of benefits based on the executive’s level, aiming to offer financial stability and maintain a committed leadership team during transitions.

For an in-depth examination of CTNM stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyContineum initiated with an Outperform at Baird
TheFlyContineum price target raised to $32 from $30 at RBC Capital
TipRanks Auto-Generated NewsdeskContineum Therapeutics Announces Corporate Presentation Updates
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App